Loss of E-cadherin tyrosine phosphorylation in human cancers

Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy.

Journal of internal medicine·2012

Symmetry breaking mechanism for epithelial cell polarization.

Physical review. E, Statistical, nonlinear, and soft matter physics·2009

Role of repulsive factors in vascularization dynamics.

Physical review. E, Statistical, nonlinear, and soft matter physics·2006

Cell directional persistence [corrected] and chemotaxis in vascular morphogenesis.

Bulletin of mathematical biology·2004

Percolation, morphogenesis, and burgers dynamics in blood vessels formation.

Physical review letters·2003

Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells.

EMBO reports·2001

Enteric viruses in HIV-related diarrhoea.

Molecular medicine today·2000

Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy.

Molecular medicine today·2000

Mining bacterial genomes for antimicrobial targets.

Molecular medicine today·2000

The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.

Molecular medicine today·2000

Does size matter? Tumor density as a predictor of clinically significant prostate cancer on MRI-targeted transperineal prostate biopsy.

International urology and nephrology·2026

Beyond the Document: A Single-Center Qualitative Study of Survivorship Care Plan Barriers and Opportunities Across Pediatric Oncology Stakeholders.

Pediatric blood & cancer·2026

A high-throughput method to computationally develop candidate adverse outcome pathways in humans: a proof of concept with insecticides and Parkinson Disease.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Endometriosis Pain: Genes linked to Inflammation Distinguish Symptomatic from Asymptomatic Disease.

Molecular human reproduction·2026

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Journal of the National Cancer Institute·2026

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

Journal of the National Cancer Institute·2026

Related Experiment Videos

Loss of E-cadherin tyrosine phosphorylation in human cancers

Related Concept Videos

Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy.

Symmetry breaking mechanism for epithelial cell polarization.

Role of repulsive factors in vascularization dynamics.

Cell directional persistence [corrected] and chemotaxis in vascular morphogenesis.

Percolation, morphogenesis, and burgers dynamics in blood vessels formation.

Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells.

Enteric viruses in HIV-related diarrhoea.

Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy.

Mining bacterial genomes for antimicrobial targets.

The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.

Does size matter? Tumor density as a predictor of clinically significant prostate cancer on MRI-targeted transperineal prostate biopsy.

Beyond the Document: A Single-Center Qualitative Study of Survivorship Care Plan Barriers and Opportunities Across Pediatric Oncology Stakeholders.

A high-throughput method to computationally develop candidate adverse outcome pathways in humans: a proof of concept with insecticides and Parkinson Disease.

Endometriosis Pain: Genes linked to Inflammation Distinguish Symptomatic from Asymptomatic Disease.

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

Related Experiment Videos

Loss of E-cadherin tyrosine phosphorylation in human cancers

Related Concept Videos

Related Articles